Swiss guidance document on the conduct of clinical trials and research projects during the COVID-19 pandemic

DUE TO THE END OF THE COVID-19 PANDEMIC, THE Swiss GUIDANCE DOCUMENT AND THE ADDENDUM TO THE PATIENT INFORMATION AND CONSENT FORM ARE NO LONGER IN FORCE. The documents are retained here for informational purposes only.

Joint guidance of swissethics - Swissmedic on the conduct of clinical trials during COVID-19 pandemic

Aufgrund der andauernden Pandemie wurde das Kapitel «Monitoring» überarbeitet. «Remote Source Data Verification» von für die Patientensicherheit und Datenintegrität kritischen Aspekten wird unter bestimmten Bedingungen im Rahmen von klinischen Versuchen mit Arzneimitteln in Zeiten der Pandemie erlaubt.

English

2.4

updated: 18.12.2020

Addendum to the patient information / consent form of clinical trials during the COVID 19 pandemic: telephone visits and home delivery of the investigational study drug

Addendum to the patients information and consent form of clinical trials during the COVID 19 pandemic: telephone visits and home delivery of the investigational study drug

Deutsch

1.0

updated: 26.03.2020

Français

1.0

updated: 26.03.2020

Italiano

1.0

updated: 26.03.2020